148 related articles for article (PubMed ID: 3264554)
1. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
Abeck D; Johnson AP; Dangor Y; Ballard RC
J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
[TBL] [Abstract][Full Text] [Related]
2. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
5. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Ismaeel NA
Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
Aldridge KE; Cammarata C; Martin DH
Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
Sturm AW
J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
Le Saux NM; Slaney LA; Plummer FA; Ronald AR; Brunham RC
Antimicrob Agents Chemother; 1987 Jul; 31(7):1153-4. PubMed ID: 2959199
[TBL] [Abstract][Full Text] [Related]
12. Episome profiles and mobilizable beta-lactamase plasmid in Haemophilus ducreyi.
Prachayasittikul V; Lawung R; Bulow L
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):80-4. PubMed ID: 11023070
[TBL] [Abstract][Full Text] [Related]
13. Plasmid-mediated tetracycline resistance in Haemophilus ducreyi.
Albritton WL; Maclean IW; Slaney LA; Ronald AR; Deneer HG
Antimicrob Agents Chemother; 1984 Feb; 25(2):187-90. PubMed ID: 6324665
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Haemophilus ducreyi.
Hammond GW; Lian CJ; Wilt JC; Ronald AR
Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
[TBL] [Abstract][Full Text] [Related]
15. Novel plasmid combinations in Haemophilus ducreyi isolates from Thailand.
Sarafian SK; Johnson SR; Thomas ML; Knapp JS
J Clin Microbiol; 1991 Oct; 29(10):2333-4. PubMed ID: 1939592
[TBL] [Abstract][Full Text] [Related]
16. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi.
Roy-Leon JE; Lauzon WD; Toye B; Singhal N; Cameron DW
J Antimicrob Chemother; 2005 Sep; 56(3):552-8. PubMed ID: 16046468
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.
Taylor DN; Echeverria P; Hanchalay S; Pitarangsi C; Slootmans L; Piot P
J Clin Microbiol; 1985 Mar; 21(3):442-4. PubMed ID: 3872313
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-coded ampicillin resistance in Haemophilus ducreyi.
Thomson JA; Bilgeri YR
Antimicrob Agents Chemother; 1982 Oct; 22(4):689-92. PubMed ID: 6983859
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
Lagergård T; Frisk A; Trollfors B
J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
